$440 Million

Madrigal Pharmaceuticals

Follow-on Offering

Lead Manager, June 2018

Madrigal Pharmaceuticals
Madrigal is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases.